Bernard Denoyer
Director/Board Member en OKYO PHARMA LIMITED .
Fortuna: - $ al 31/03/2024
Perfil
Bernard F.
Denoyer is currently a Non-Executive Director at OKYO Pharma Ltd.
He is also a Trustee at St. Edmunds Retreat, Inc. and Midwestern Connecticut Council of Alcoholism, Inc. In the past, he worked as the Chief Financial Officer & Senior Vice President at META Group, Inc. and as the Chief Financial Officer, Secretary & Senior VP at Callisto Pharmaceuticals, Inc. He was also a Vice President-Finance at Environetics, Inc. and a Secretary & Senior Vice President at Synergy Pharmaceuticals LLC.
Additionally, he served as a Trustee at Pawfect Foods, Inc. and as the Chief Financial Officer, Secretary & Senior VP at Hepion Pharmaceuticals, Inc. Mr. Denoyer received his undergraduate degree from Fairfield University and his MBA degree from Columbia Business School.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
OKYO PHARMA LIMITED
-.--% | 28/07/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Bernard Denoyer
Empresas | Cargo | Inicio |
---|---|---|
OKYO PHARMA LIMITED | Director/Board Member | 01/12/2021 |
St. Edmunds Retreat, Inc. | Director/Board Member | - |
Midwestern Connecticut Council of Alcoholism, Inc. | Director/Board Member | - |
Antiguos cargos conocidos de Bernard Denoyer.
Empresas | Cargo | Fin |
---|---|---|
SYNERGY PHARMACEUTICALS INC | Director of Finance/CFO | 17/04/2017 |
HEPION PHARMACEUTICALS, INC. | Director of Finance/CFO | 23/06/2014 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Director of Finance/CFO | 22/01/2013 |
Pawfect Foods, Inc. | Director of Finance/CFO | 11/08/2008 |
META Group, Inc.
META Group, Inc. Miscellaneous Commercial ServicesCommercial Services META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT. | Director of Finance/CFO | 01/09/2000 |
Formación de Bernard Denoyer.
Fairfield University | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
OKYO PHARMA LIMITED | Health Technology |
HEPION PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 7 |
---|---|
META Group, Inc.
META Group, Inc. Miscellaneous Commercial ServicesCommercial Services META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT. | Commercial Services |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
Pawfect Foods, Inc. | Retail Trade |
Environetics, Inc.
Environetics, Inc. Wholesale DistributorsDistribution Services Part of Alanco Technologies, Inc., Environetics, Inc. is committed to improving water quality through the development of products which help to solve industrial and municipal water and wastewater quality problems. The private company is based in Scottsdale, AZ. The company produces tank & clearwell baffles and covers that provide practical solutions for improving water, wastewater, and air quality. Environetics improves waste treatment by offering a quick, efficient, and satisfactory way to upgrade tank based waste treatment operations through the installation of a Director II system. Environetics was acquired by Alanco Technologies, Inc. on January 06, 1995. | Distribution Services |
St. Edmunds Retreat, Inc. | |
Midwestern Connecticut Council of Alcoholism, Inc. | |
Synergy Pharmaceuticals LLC
Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Bernard Denoyer